Avivagen Announces Two Appointments to its Board of Directors, Mr. David Allan and Ms. Vanessa Grant
ACCESSWIRE - Thu May 14, 6:34AM CDT
OTTAWA, ON/ ACCESSWIRE / May 14 2015 / Avivagen Inc. (TSXV:VIV, PINKSHEETS:CHEXF), a life sciences company that develops and delivers products that support and enhance the health of livestock, pets and people, announces the appointment of two new Directors, Mr. David Allan and Ms. Vanessa Grant, and the resignation of two past Directors, Dr. Janusz Daroszewski and Dr. Chandra Panchal.
Avivagen Announces Presentation at Bloom Burton & Co. Conference on May 4, 2015
ACCESSWIRE - Fri May 01, 6:36AM CDT
OTTAWA, ON / ACCESSWIRE / May 1, 2015 / Avivagen Inc. (TSX VENTURE: VIV, PINKSHEETS: CHEXF), a life sciences company that develops and delivers products that support and enhance the health of livestock, pets and people, announces that it will be presenting at the Bloom Burton & Co. Healthcare Investment Conference on May 4th, 2015.
Avivagen Announces Abstract Presentation of Final Poultry Trial Results at Symposium of the Korean Society of Veterinary Science
ACCESSWIRE - Wed Apr 29, 6:35AM CDT
OTTAWA, ON / ACCESSWIRE / April 29, 2015 / Avivagen Inc. (TSX VENTURE: VIV, PINKSHEETS: CHEXF), a life sciences company that develops and delivers products that support and enhance the health of livestock, pets and people, announces the presentation of a scientific abstract summarizing the results of the poultry trial run by Chonbuk National University of the Republic of Korea.
Avivagen Announces CEO Update
ACCESSWIRE - Thu Apr 16, 6:38AM CDT
OTTAWA, ON / ACCESSWIRE / Apr 16 2015 / Avivagen Inc. (TSX VENTURE:VIV, PINKSHEETS:CHEXF), a life sciences company that develops and delivers products that support and enhance the health of livestock, pets and people, announces the release and website posting of a letter from its CEO providing updates about the company and its business plans. In addition to reading the letter, we encourage you to visit the Avivagen website at www.avivagen.com to learn more.
Avivagen Summarizes Final Aquaculture Trial Results
ACCESSWIRE - Fri Apr 10, 6:34AM CDT
OTTAWA, ON / ACCESSWIRE / April 10, 2015 / Avivagen Inc. (TSX VENTURE:VIV), (PINKSHEETS:CHEXF), a life sciences company that develops and delivers products that support and enhance the health of livestock, pets and people, provides a summary of the final results of the first exploratory evaluation of Avivagen's proprietary OxC-beta in aquaculture under production conditions; a tilapia trial run by Nam Sai Farms of Thailand.
VIV.VN: 0.080 (-0.010)
Avivagen Announces Publication of an Opinion-Editorial In Ottawa's "The Hill Times" Newspaper
TheNewswire.ca - Mon Mar 30, 5:31PM CDT
(via Thenewswire.ca)
VIV.VN: 0.080 (-0.010)
Avivagen Announces Launch of New Consumer-Friendly E-Commerce Website
ACCESSWIRE - Mon Mar 23, 6:33AM CDT
OTTAWA, ON / ACCESSWIRE / March 23, 2015 / Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF), a life sciences company that develops and delivers products that support and enhance the health of livestock, pets and people, announces the launch of its new consumer-friendly e-commerce website.
Avivagen Announces Voting Results for the Election of its Directors
ACCESSWIRE - Fri Mar 13, 6:35AM CDT
OTTAWA, ON / ACCESSWIRE / March 13, 2015 / Avivagen Inc. (TSXV: VIV), a life sciences company that develops and delivers products that support and enhance the health of livestock, pets and people, announces the results of shareholder voting for the election of its directors.
VIV.VN: 0.080 (-0.010)
Avivagen Summarizes Final Poultry Trial Results
ACCESSWIRE - Tue Mar 03, 6:38AM CST
OTTAWA, ON / ACCESSWIRE / March 3, 2015 / Avivagen Inc. (TSX Venture:VIV), (PINKSHEETS:CHEXF), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, provides a summary of the final results of the poultry trial that was run by Chonbuk National University of the Republic of Korea.
VIV.VN: 0.080 (-0.010)
Avivagen & Bayer Terminate U.S. Distribution Agreement for Oximunol Chewable Tablets
ACCESSWIRE - Mon Feb 16, 6:34AM CST
OTTAWA, ON / ACCESSWIRE / February 16, 2015 / Avivagen Inc. (TSXV:VIV, OTC Pink: CHEXF), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, announces the termination of its U.S. product distribution agreement with the Animal Health division of Bayer Healthcare LLC.
Avivagen Summarizes Final Swine Trial Results
ACCESSWIRE - Wed Feb 11, 6:37AM CST
OTTAWA, ON / ACCESSWIRE / February 11, 2015 / Avivagen Inc. (TSXV: VIV), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, provides a summary of the final results of the swine trial that was run by the National Institute of Animal Sciences for Vietnam.
VIV.VN: 0.080 (-0.010)